Deepak Bhere

2.0k total citations · 1 hit paper
27 papers, 1.3k citations indexed

About

Deepak Bhere is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Deepak Bhere has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Deepak Bhere's work include Virus-based gene therapy research (5 papers), CAR-T cell therapy research (4 papers) and Cancer Mechanisms and Therapy (4 papers). Deepak Bhere is often cited by papers focused on Virus-based gene therapy research (5 papers), CAR-T cell therapy research (4 papers) and Cancer Mechanisms and Therapy (4 papers). Deepak Bhere collaborates with scholars based in United States, Saudi Arabia and Japan. Deepak Bhere's co-authors include Khalid Shah, Hiroaki Wakimoto, Erika M. J. Siren, Reza Abdi, Brock Reeve, Ali H. Alhasan, Yuka Milton, Rui Kuai, Oren Levy and Abdulaziz Almalik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hepatology and Cancer Research.

In The Last Decade

Deepak Bhere

25 papers receiving 1.3k citations

Hit Papers

Shattering barriers toward clinically meaningful MSC ther... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepak Bhere United States 15 604 571 355 290 191 27 1.3k
Paula Yeng Po Lam Singapore 19 927 1.5× 401 0.7× 419 1.2× 309 1.1× 133 0.7× 49 1.6k
Audrey Rousseau France 23 660 1.1× 734 1.3× 431 1.2× 425 1.5× 137 0.7× 89 1.9k
Marta Baiocchi Italy 19 794 1.3× 396 0.7× 459 1.3× 208 0.7× 289 1.5× 38 1.5k
Ivy A. W. Ho Singapore 18 526 0.9× 370 0.6× 291 0.8× 262 0.9× 87 0.5× 28 1.0k
Dongdong Ti China 20 937 1.6× 535 0.9× 801 2.3× 305 1.1× 250 1.3× 31 2.1k
François Mercier Canada 16 1.1k 1.8× 325 0.6× 311 0.9× 428 1.5× 208 1.1× 51 2.1k
Helen Wheadon United Kingdom 20 768 1.3× 381 0.7× 236 0.7× 93 0.3× 96 0.5× 53 1.6k
Stefan Radtke United States 19 1.4k 2.3× 516 0.9× 255 0.7× 554 1.9× 162 0.8× 56 2.1k
Malte Mohme Germany 22 427 0.7× 342 0.6× 698 2.0× 319 1.1× 251 1.3× 61 1.7k
Alexis S. Bailey United States 14 875 1.4× 374 0.7× 339 1.0× 207 0.7× 321 1.7× 17 1.6k

Countries citing papers authored by Deepak Bhere

Since Specialization
Citations

This map shows the geographic impact of Deepak Bhere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Bhere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Bhere more than expected).

Fields of papers citing papers by Deepak Bhere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Bhere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Bhere. The network helps show where Deepak Bhere may publish in the future.

Co-authorship network of co-authors of Deepak Bhere

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Bhere. A scholar is included among the top collaborators of Deepak Bhere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Bhere. Deepak Bhere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valdés, Pablo A., Chih-Chieh Yu, Debarati Ghosh, et al.. (2024). Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowding. Science Translational Medicine. 16(732). eabo0049–eabo0049. 9 indexed citations
2.
Tamura, Kaoru, et al.. (2024). Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas. Molecular Therapy. 32(5). 1595–1595. 1 indexed citations
3.
4.
Kuruppu, Darshini, Deepak Bhere, Christian T. Farrar, et al.. (2023). Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases. Cancer Gene Therapy. 30(6). 833–844. 6 indexed citations
5.
Gourishetti, Karthik, et al.. (2023). MicroRNA (miR)-124: A Promising Therapeutic Gateway for Oncology. Biology. 12(7). 922–922. 9 indexed citations
6.
Bhere, Deepak, et al.. (2021). Oncolytic Herpes Simplex Virus-Based Therapies for Cancer. Cells. 10(6). 1541–1541. 55 indexed citations
7.
Cingöz, Ahmet, Tunç Morova, Fidan Seker-Polat, et al.. (2021). Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene. 40(18). 3201–3216. 9 indexed citations
8.
Bhere, Deepak, et al.. (2020). Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy. Scientific Reports. 10(1). 1779–1779. 36 indexed citations
9.
Nawab, Khalid, et al.. (2019). Stem Cell Therapies: A Way to Promising Cures. Cureus. 11(9). e5712–e5712. 16 indexed citations
10.
Reinshagen, Clemens, et al.. (2018). CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors. Science Translational Medicine. 10(449). 42 indexed citations
11.
Kuruppu, Darshini, Deepak Bhere, Christian T. Farrar, et al.. (2018). A model of breast cancer meningeal metastases: characterization with in vivo molecular imaging. Cancer Gene Therapy. 26(5-6). 145–156. 7 indexed citations
12.
Zhu, Yanni, Clemens Reinshagen, Deepak Bhere, et al.. (2017). Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors. Scientific Reports. 7(1). 2602–2602. 32 indexed citations
13.
Bhere, Deepak, et al.. (2015). Selective cytotoxicity and pro-apoptotic activity of stem bark of Wrightia tinctoria (Roxb.) R. Br. in cancerous cells. Pharmacognosy Magazine. 11(44). 481–481. 4 indexed citations
14.
Bhere, Deepak & Khalid Shah. (2015). Stem Cell-Based Therapies for Cancer. Advances in cancer research. 127. 159–189. 10 indexed citations
15.
Sullivan, James P., Brian V. Nahed, Marissa W. Madden, et al.. (2014). Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression. Cancer Discovery. 4(11). 1299–1309. 200 indexed citations
16.
Tamura, Kaoru, et al.. (2014). Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas. Molecular Therapy. 23(2). 235–243. 50 indexed citations
17.
Srivastava, Jyoti, Chadia L. Robertson, Devaraja Rajasekaran, et al.. (2014). AEG-1 Regulates Retinoid X Receptor and Inhibits Retinoid Signaling. Cancer Research. 74(16). 4364–4377. 40 indexed citations
18.
Hingtgen, Shawn, José Luiz de Figueiredo, Christian T. Farrar, et al.. (2012). Real-time multi-modality imaging of glioblastoma tumor resection and recurrence. Journal of Neuro-Oncology. 111(2). 153–161. 48 indexed citations
19.
Srivastava, Jyoti, Ayesha Siddiq, Luni Emdad, et al.. (2012). Astrocyte elevated gene-1 promotes hepatocarcinogenesis: Novel insights from a mouse model. Hepatology. 56(5). 1782–1791. 66 indexed citations
20.
Tamura, Kaoru, Hiroaki Wakimoto, Samuel D. Rabkin, et al.. (2012). Multimechanistic Tumor Targeted Oncolytic Virus Overcomes Resistance in Brain Tumors. Molecular Therapy. 21(1). 68–77. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026